The effectiveness of ovulation induction and intrauterine insemination in the treatment of persistent infertility: a meta-analysis

Edward G. Hughes, E. G. Hughes, Hughes EG
Human Reproduction · 1997 · vol. 12(9) , pp. 1865–1872 · doi:10.1093/humrep/12.9.1865 · PMID:9363697 · W2101437858
Systematic review / meta-analysis OA: closed CC0 ⤵ 62 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-10 ⓘ

This meta-analysis found that FSH with IUI significantly improves pregnancy rates for unexplained infertility and identified independent effects of FSH, clomiphene citrate, IUI, male factor, and endometriosis on pregnancy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A systematic review was conducted to evaluate the effectiveness of intrauterine insemination (IUI) with or without ovarian stimulation using gonadotrophin in the treatment of persistent infertility. Relevant randomized controlled trials were identified by a diverse strategy including a hand search of 43 core journals from 1966 to the present. Two approaches to meta-analysis were used to summarize data. First, using a standard Mantel-Haenszel approach, eight trials comparing FSH/IUI with FSH/timed intercourse for unexplained infertility were combined. The common odds ratio for pregnancy was 2.37 [95% confidence interval (CI), 1.43, 3.90], suggesting a significant improvement with IUI following ovulation induction in this patient group. Although the data were statistically homogeneous, clinically important heterogeneity was present. Second, across all diagnostic groups, the independent effects of treatment with follicle stimulating hormone (FSH), clomiphene citrate, IUI, as well as the diagnoses of male factor and endometriosis were assessed using stepwise logistic regression. Based on 5214 cycles reported in 22 trials, the odds ratio for pregnancy associated with FSH use was 2.35 (95% CI, 1.87, 2.94) for IUI, 2.82 (95% CI, 2.18, 3.66) for male factor, 0.48 (95% CI, 0.37, 0.61), and for endometriosis 0.45 (95% CI, 0.27, 0.76). This summary of the best available evidence may prove useful in counselling couples who are considering FSH and/or IUI therapy.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

MeSH descriptors

Infertility Insemination, Artificial Insemination, Artificial Ovulation Induction Ovulation Induction Clomiphene Clomiphene Clomiphene Female Female Follicle Stimulating Hormone Follicle Stimulating Hormone Follicle Stimulating Hormone Humans Humans Infertility Infertility Logistic Models Logistic Models Male

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (9)

Cited by (50)

Source provenance

europepmc
last seen: 2026-10-17T06:09:56.316927+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T22:00:28.864438+00:00
License: CC0 · commercial use OK